Blagoveschensk, Russian Federation
Blagoveschensk, Blagoveshchensk, Russian Federation
Pre-eclampsia/eclampsia is one of the most serious pregnancy complications in modern obstetrics. The article presents the historical data about the study of pre-eclampsia and eclampsia since the 4th century BC. The evolution of terminology is presented. According to the development of medical science there appeared a new theory of the etiology and the conception of pathogenesis developed. It shows the contribution of Russian scientists to improve methods of diagnosis, treatment and prevention of this complication of pregnancy. The achievements of modern obstetric science allow to predict pre-eclampsia from early pregnancy. Despite long history of studying, many aspects of this problem still remain unresolved.
pre-eclampsia, eclampsia
1. Arifkhanov R.I. Human placental gamma-globulin as an inhibitor reaction transplantation immunity: abstract of PhD thesis. Moscow; 1984 (in Russian).
2. Benediktov I.I., Pirogovskiy L.P. Pretoxemia and toxemia of pregnancy. Sverdlovsk; 1978 (in Russian).
3. Bystritskaya T.S. Gestoses of pregnant. Preventing severe. Blagoveshchensk: AGMA; 1995 (in Russian).
4. Vikhlyaeva E.M. Controversial issues of treatment of late toxicosis pregnant. Akusherstvo i ginekologiya 1976; 6:4 (in Russian).
5. Genter G.G. Obstetrics textbook. Leningrad: Biomedgiz; 1937 (in Russian).
6. Grishchenko V.I. Late toxicosis pregnant. Kiev: Zdorov’ya; 1968 (in Russian).
7. Grishchenko V.I., Shcherbina N.A. Current approaches to diagnosis and treatment of preeclampsia. Akusherstvo i ginekologiya 1988; 9:60–63 (in Russian).
8. Zhordaniya I.F. Obstetrics textbook. Moscow: Medgiz; 1964 (in Russian).
9. Zhuchenko P.G. Immunogenetics and pregnancy toxicosis. Kiev: Zdorov’ya; 1977 (in Russian).
10. Ziganshina M.M., Shilova N.V., Khasbiullina N.R., Novakouski M.E., Nikolaeva M.A., Kan N.E., Vavina O.V., Nikolaeva A.V., Tyutyunnik N.V., Sergunina O.A., Bot I., Tyutyunnik V.L., Bovin N.V., Sukhikh G.T. Autoantibodies against endothelial antigens in preeclampsia. Akusherstvo i ginekologiya 2016; 3:24–31 (in Russian).
11. Ivanets T.Yu., Alekseeva M.L., Goncharova E.A., Khodzhaeva Z.S., Vavin O.V. The markers of preeclampsia in the first and second trimesters of pregnancy. Problemy reproduktsii 2012; 3:83–87 (in Russian).
12. Ivanov I.P. Late toxemia of pregnancy (pathogenesis, therapy and antenatal protection of the fetus): abstract of PhD (DSc) thesis. Moscow; 1969 (in Russian).
13. Kan N.E., Bednyagin L.A., Tyutyunnik V.L., Khovkhaeva P.A., Donnikov A.E., Dolgushina N.V. Significance of detoxification system gene polymorphisms in preeclampsia. Akusherstvo i ginekologiya 2016; 2:8–13 (in Russian).
14. Kozlov L.A. Eclampsia: problems, successes, forecasts. Kazanskiy meditsinskiy zhurnal 1985; 66(1):1–4 (in Russian).
15. Mikhnov S.D. On the question of the etiology of eclampsia based on clinical data. St. Petersburg; 1899 (in Russian).
16. Nikolaev A.P. Late toxicosis pregnant. Moscow: Meditsina; 1972 (in Russian).
17. Persianinov L.S. Obstetric seminar, Vol.2. Tashkent: Meditsina; 1973 (in Russian).
18. Persianinov L.S., Rasstrigin N.N. Emergency care in obstetrics and gynecology. Tashkent: Meditsina; 1983 (in Russian).
19. Petrov-Maslakov M.A., Sotnikova L.G. Late toxicosis pregnant. Leningrad: Meditsina; 1971 (in Russian).
20. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. World Health Organization; 2014 (in Russian).
21. Stroganov V.V. For the treatment of eclampsia. Sovremennaya meditsina i gigiena 1899; 2 (in Russian).
22. Khaitov R.M., Verbitskiy M.Sh. The ontogeny of the immune system. Results of science and technology. Immunology. Moscow: Meditsina; 1986 (in Russian).
23. Tsvelev Y.V. The role of Nikolai Pirogov in development of domestic obstetrics and gynecology. Zhurnal akusherstva i zhenskikh bolezney 2003; 52(4):77–81 (in Russian).
24. Bar J., Hod M., Pardo J., Fisch B., Rabinerson D., Kaplan B., Meizner I. Effect on fetal circulation of low-dose aspirin for prevention and treatment of pre-eclampsia and intrauterine growth restriction: Doppler flow study. Ultrasound Obstet. Gynecol. 1997; 9(4):262–265.
25. Beker J. C. Aetiology of eclampsia. Br. J. Obstet. Gynecol. 1948; 55(6):756–765.
26. Brosens I., Renaer M. On the pathogenesis of placental infarcts in pre-eclampsia. J. Obstet. Gynaecol. Br. Commonw. 1972; 79(9):794–799.
27. Carey H. M. Ion exchange resins in the treatment and prophylaxis of pre-eclampsia. Obstet. Gynecol. 1953; 1(2):177–182.
28. Chen G. L., Wilson R., Wang S.H., Zheng H.Z., Walker J.J., McKillop J.H. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin. Exp. Immunol. 1996; 104(1):154–159.
29. Clark J.F., Jackson L.A. Jr., Gray J.C. Chlorothiazide in the treatment of toxemia of pregnancy. J. Natl. Med. Assoc. 1963; 55(1):23–25.
30. Conde-Agudelo A., Romero R., Lindheimer M.D. Tests to predict preeclampsia. In: Lindheimer M., Roberts J., Cunningham G.C. (eds). Chesley’s hypertensive disorders in pregnancy. 3rd. ed. New York: Academic Press, 2009.
31. Davidge S.T., Signorella A.P., Hubel C.A., Lykins D.L., Roberts J.M. Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin. Hypertension 1996; 28(5):758–764.
32. De Lee J.B. Theories of eclampsia. Am. J. Obstet. Gynecol. 1905; 51:325–330.
33. Duley L. Aspirin for preventing and treating pre-eclampsia. B.M.J. 1999; 318(7186):751–752.
34. Duda J. Preeclampsia still an Enigma. West. J. Med. 1996; 164(4):315–320.
35. Eshkoli T., Holcberg G., Bronfenmacher B., Amash A., Huleihel M., Erez O. Perfusion with magnesium sulfate increases sFlt-1 secretion only in the fetal side of placenta of women with preeclampsia. J. Mater. Fetal Neonatal Med. 2013; 26(2):116–122.
36. Fievet P., Tribout B., Verhoest P., Dufour F., Boulanger J.C., Vitse M., Fournier A. Physiopathology of pregnancy-induced hypertension. Revue Francaise de Gynecologie et d Obstetrique 1984; 79(12):759–764.
37. Genbacev O., Joslin R., Damsky C.H., Polliotti B.M., Fisher S.J. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J. Clin. Invest. 1996; 97(2):540–550.
38. Hans S.F., Kopelman H. Methyldopa in Treatment of Severe Toxaemia of Pregnancy. Br. Med. J. 1964; 1(5385):736–739.
39. Hunter A., Aitkenhead M., Caldwell C. McCracken G., Wilson D., McClure N. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension 2000; 36(6):965–969.
40. Lam C., Lim K.H., Karumanchi S.A. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 2005; 46(5):1077–1085.
41. Lever J.С.W. Cases of puerperal convulsions with remarks. Guy´s Hospital Reports 1843; 1:495–517.
42. Loudon I. Some historical aspects of toxemia of pregnancy. A review. Br. J. Obstet. Gynecol. 1991; 98(9):853–858.
43. Lucas M.J., Leveno K.J., Cunningham F.G. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N. Engl. J. Med. 1995; 333(4):201–205.
44. Lyall F., Greer I.A. The vascular endothelium in normal pregnancy and pre-eclampsia. Rev. Reprod. 1996; 1(2):107–116.
45. McClure Browne J.C. Discussion on the aetiology of pre-eclampsia. Proc. R. Soc. Med. 1957; 50(10):787–788.
46. Mignini L.E., Latthe P.M., Villar J., Kilby M.D., Carroli G., Khan K.S. Mapping the theories of preeclampsia: the role of homocysteine. Obstet. Gynecol. 2005; 105(5):411–425.
47. Redman C.W.G., Bodmer W.F., Bodmer J.G., Beilin L.J., Bonnar J. HLA antigens in severe pre-eclampsia. Lancet 1978; 312(8086):397–399.
48. Redman C.W.G. Treatment of hypertension in pregnancy. Kidney International 1980; 18(2):267–278.
49. Ringrose C.A. Psychosomatic influences in the genesis of toxemia of pregnancy. Can. Med. Assoc. J. 1961; 84(12):647–651.
50. Russell P.M.G. Pre-eclampsia in the light of current research. Postgrad. Med. J. 1950; 26(299):488–490.
51. Sadeh M. Action of magnesium sulfate in the treatment of preeclampsia-eclampsia. Stroke 1989; 20(9):1273–1275.
52. Schobel H.P., Fischer T., Heuszer K., Geiger H., Schmieder R.E. Preeclampsia – a state of sympathetic overactivity. N. Engl. J. Med. 1996; 335(20):1480–1485.
53. Scott J. S., Jenkins D. M. Immunogenetic factors in aetiology of pre-eclampsia/eclampsia (gestosis). J. Med. Genet. 1976; 13(3):200–207.
54. Sophian J. The Cause of Pregnancy Toxemia. Proc. R. Soc. Med. 1957; 50(10):790–792.
55. Sridama V., Yang S.L., Moawad A., DeGroot L.J. T-cell subsets in patients with preeclampsia. Am. J. Obstet. Gynecol. 1983; 147(5):566–569.
56. Zangemeister W. Die lehre von der eklampsie auf grund eigener untersuchungen. Leipzig: Verlag von S. Hirzel, 1926.
57. Zusterzeel P.L., te Morsche R.H., Raijmakers M.T., Roes E.M., Peters W.Н., Steegers-Theunissen R.P., Steegers E.A. N-acetyl-transferase phenotype and risk for preeclampsia. Am. J. Obstet. Gynecol. 2005; 193(3Pt.1):797–802.
